Rothschild & Co Asset Management US’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-9,104
Closed -$1.14M 386
2017
Q2
$1.14M Buy
9,104
+740
+9% +$88.5K 0.01% 366
2017
Q1
$994K Sell
8,364
-392
-4% -$47.1K 0.01% 369
2016
Q4
$1.01M Buy
8,756
+1,963
+29% +$218K 0.01% 387
2016
Q3
$710K Buy
6,793
+2,213
+48% +$231K 0.01% 369
2016
Q2
$446K Buy
4,580
+627
+16% +$59.3K 0.01% 433
2016
Q1
$380K Buy
3,953
+945
+31% +$86K 0.01% 376
2015
Q4
$273K Buy
+3,008
New +$283K 0.01% 401

Other funds holding CME

Rothschild & Co Asset Management US's CME Position: Q3 2017 in Review

Rothschild & Co Asset Management US sold out of CME Group (CME) in Q3 2017, closing a stake of 9,104 shares — an estimated $1.14M sold.

Rothschild & Co Asset Management US first reported a position in CME in Q4 2015 and held it in 7 quarters. The position peaked at $1.14M in Q2 2017. 760 funds tracked by Wall St. Rank hold CME as of Q3 2017.

  • Rothschild & Co Asset Management US reported no remaining CME Group position as of Q3 2017 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 9,104 CME Group shares in Q3 2017, an estimated $1.14M.
  • Rothschild & Co Asset Management US first reported a position in CME Group in Q4 2015 and held it in 7 quarters.
  • Rothschild & Co Asset Management US's CME Group position peaked at $1.14M in Q2 2017.
  • 760 funds tracked by Wall St. Rank held CME Group as of Q3 2017.

Based on Rothschild & Co Asset Management US's 13F filing for Q3 2017, filed 8 Nov 2017.